Case Study

Leveraging Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program

Certara's support, from dose optimization to medical writing, helps pharmaceutical companies advance their research, make…

CertaraJune 1, 2023

Publication

Population pharmacokinetic model of ivermectin in mass drug administration against lymphatic filariasis

Find out how sex affects ivermectin peripheral distribution; infection status does not, modelled using Phoenix…

CertaraJune 1, 2023

Conference

American College of Toxicology 2026 Annual Meeting

– – Booth

Kevin Snyder, PhDMay 24, 2023

Publication

Effects of plateau hypoxia on population pharmacokinetics and pharmacodynamics of metformin in patients with Type 2 diabetes

Explore how high‑altitude hypoxia increases metformin AUC and half‑life; PK‑PD modelling supports extended dosing intervals.

CertaraApril 28, 2023

Publication

Optimization of polymyxin B regimens for the treatment of carbapenem-resistant organism nosocomial pneumonia: a real-world prospective study

Discover how AUC/MIC ≥ 66.9 predicts efficacy; modelling supports 75–100 mg q12h dosing for CRO…

CertaraApril 28, 2023

Publication

Comparative Bioequivalence of Tablet and Capsule Formulations of Ulotaront and the Effect of Food on the Pharmacokinetics of the Tablet Form in Humans

See how tablet and capsule are bioequivalent; food delays Tmax without affecting exposure, analysed using…

CertaraMarch 17, 2023

Publication

Population pharmacokinetics and limited sampling strategies of polymyxin B in critically ill patients

Learn how PopPK modelling supports limited sampling strategies and individualized polymyxin B dosing using Phoenix…

CertaraMarch 2, 2023

Publication

Simultaneous pharmacokinetic assessment of phytopharmaceuticals in fenugreek extract using LC-MS/MS in Sprague-Dawley rats

Simultaneous PK profiling of four fenugreek phytochemicals in rats, supporting development of fenugreek‑based formulations by…

CertaraFebruary 27, 2023

Publication

Population pharmacokinetic analysis of TQ-B3203 following intravenous administration of TQ-B3203 liposome injection in Chinese patients with advanced solid tumors

See how PopPK modelling shows bilirubin, BMI, and lean body weight meaningfully affect TQ‑B3203 clearance…

CertaraJanuary 16, 2023

Publication

Pharmacokinetics and Bioequivalence of the Lubiprostone Capsule in Healthy Chinese Subject

Learn how dose‑proportional PK and fed‑state bioequivalence confirmed for lubiprostone using Phoenix WinNonlin.

CertaraJanuary 10, 2023

Certara Products – Phoenix

Leveraging Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program

Population pharmacokinetic model of ivermectin in mass drug administration against lymphatic filariasis

American College of Toxicology 2026 Annual Meeting

Effects of plateau hypoxia on population pharmacokinetics and pharmacodynamics of metformin in patients with Type 2 diabetes

Optimization of polymyxin B regimens for the treatment of carbapenem-resistant organism nosocomial pneumonia: a real-world prospective study

Comparative Bioequivalence of Tablet and Capsule Formulations of Ulotaront and the Effect of Food on the Pharmacokinetics of the Tablet Form in Humans

Population pharmacokinetics and limited sampling strategies of polymyxin B in critically ill patients

Simultaneous pharmacokinetic assessment of phytopharmaceuticals in fenugreek extract using LC-MS/MS in Sprague-Dawley rats

Population pharmacokinetic analysis of TQ-B3203 following intravenous administration of TQ-B3203 liposome injection in Chinese patients with advanced solid tumors

Pharmacokinetics and Bioequivalence of the Lubiprostone Capsule in Healthy Chinese Subject

Newsletter sign up

Quick links

Solutions

Contact